Literature DB >> 8398810

Effect of chronic graft-versus-host disease on the intestine in adult BDF1 mice.

B de Geus1, H Hogenesch, E de Heer, J A Bruijn, M van den Enden, J Rozing.   

Abstract

This study was performed to characterize the intestinal lesions in chronic graft-versus-host disease (GVHD) in mice and to determine a possible role of intestinal intraepithelial lymphocytes (ilEL) in the development of these lesions. Chronic GVHD was induced by transfer of DBA/2 lymphocytes into non-irradiated (C57BL/10 x DBA/2)F1 (BDF1) recipients. There was mild to moderate mucosal oedema with multifocal mixed inflammatory cell infiltrations in the small intestine. The caecum was more severely affected with severe oedema, progressive loss of crypts and severe distortion of the mucosal architecture. The total number of ilEL did not change during the development of chronic GVHD, but there were alterations in the composition of the ilEL population. An increase of CD3+, Thy-1+ cells was accompanied by an increase of TCR alpha beta + cells and a decrease of TCR gamma delta + cells. There was no evidence of infiltration of donor lymphocytes into the intestinal epithelium as determined by the H2K haplotype of the ilEL. These lesions differ from previously described models of chronic GVHD, induced by DBA/2 donor lymphocytes in BDF1 recipients. We suggest that the haemopoietic organs that are used as the source of donor lymphocytes determine the outcome of the GVHD. Modulation of the composition of the donor lymphocyte population may be useful in the establishment of relevant animal models of human enteropathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398810      PMCID: PMC2001844     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  30 in total

1.  Expression of the gamma-delta T-cell receptor on intestinal CD8+ intraepithelial lymphocytes.

Authors:  T Goodman; L Lefrançois
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

Review 2.  Immunologic, clinical, and pathologic aspects of human graft-versus-host disease.

Authors:  M R Wick; S B Moore; D A Gastineau; H C Hoagland
Journal:  Mayo Clin Proc       Date:  1983-09       Impact factor: 7.616

3.  Augmentation of intestinal and peripheral natural killer cell activity during the graft-versus-host reaction in mice.

Authors:  A Borland; A M Mowat; D M Parrott
Journal:  Transplantation       Date:  1983-11       Impact factor: 4.939

Review 4.  Graft-versus-host disease.

Authors:  R P Gale
Journal:  Immunol Rev       Date:  1985-12       Impact factor: 12.988

5.  Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine.

Authors:  A M Mowat; A Ferguson
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

6.  Evidence that Ia+ bone-marrow-derived cells are the stimulus for the intestinal phase of the murine graft-versus-host reaction.

Authors:  A M Mowat
Journal:  Transplantation       Date:  1986-08       Impact factor: 4.939

7.  Experimental studies of immunologically mediated enteropathy. III. Severe and progressive enteropathy during a graft-versus-host reaction in athymic mice.

Authors:  A M Mowat; M V Felstein; M E Baca
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

8.  Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms.

Authors:  D Guy-Grand; P Vassalli
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

9.  Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.

Authors:  C S Via; S O Sharrow; G M Shearer
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

10.  Amplification of the graft-versus-host reaction by partial body irradiation.

Authors:  S Lehnert; W B Rybka; T A Seemayer
Journal:  Transplantation       Date:  1986-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.